Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

Traumatic Brain Injury Patients Mortality and Serum Total Antioxidant Capacity.

Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Abreu-González P, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Brain Sci. 2020 Feb 18;10(2). pii: E110. doi: 10.3390/brainsci10020110.

2.

High serum substance P levels and mortality after malignant middle cerebral artery infarction.

Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Argueso M, Ramos L, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

J Crit Care. 2020 Jan 20;57:1-4. doi: 10.1016/j.jcrc.2020.01.022. [Epub ahead of print]

PMID:
31991332
3.

Sepsis-associated acute respiratory distress syndrome in individuals of European ancestry: a genome-wide association study.

Guillen-Guio B, Lorenzo-Salazar JM, Ma SF, Hou PC, Hernandez-Beeftink T, Corrales A, García-Laorden MI, Jou J, Espinosa E, Muriel A, Domínguez D, Lorente L, Martín MM, Rodríguez-Gallego C, Solé-Violán J, Ambrós A, Carriedo D, Blanco J, Añón JM, Reilly JP, Jones TK, Ittner CA, Feng R, Schöneweck F, Kiehntopf M, Noth I, Scholz M, Brunkhorst FM, Scherag A, Meyer NJ, Villar J, Flores C.

Lancet Respir Med. 2020 Jan 23. pii: S2213-2600(19)30368-6. doi: 10.1016/S2213-2600(19)30368-6. [Epub ahead of print]

PMID:
31982041
4.

Should MASP-2 Deficiency Be Considered a Primary Immunodeficiency? Relevance of the Lectin Pathway.

García-Laorden MI, Hernández-Brito E, Muñoz-Almagro C, Pavlovic-Nesic S, Rúa-Figueroa I, Briones ML, Rajas O, Borderías L, Payeras A, Lorente L, Freixinet J, Ferreres J, Obando I, González-Quevedo N, Rodríguez de Castro F, Solé-Violán J, Rodríguez-Gallego C.

J Clin Immunol. 2019 Dec 11. doi: 10.1007/s10875-019-00714-4. [Epub ahead of print]

PMID:
31828694
5.

Maintained high sustained serum malondialdehyde levels after severe brain trauma injury in non-survivor patients.

Lorente L, Martín MM, Abreu-González P, Ramos L, Cáceres JJ, Argueso M, Solé-Violán J, Jiménez A, García-Marín V.

BMC Res Notes. 2019 Dec 3;12(1):789. doi: 10.1186/s13104-019-4828-5.

6.

Higher Serum Melatonin Levels during the First Week of Malignant Middle Cerebral Artery Infarction in Non-Surviving Patients.

Lorente L, Martín MM, Abreu-González P, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Brain Sci. 2019 Nov 28;9(12). pii: E346. doi: 10.3390/brainsci9120346.

7.

High Serum Tissue Inhibitor of Matrix Metalloproteinase-1 Levels and Mortality in Patients with Spontaneous Intracerebral Hemorrhage.

Lorente L, Martín MM, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A.

World Neurosurg. 2020 Feb;134:e476-e480. doi: 10.1016/j.wneu.2019.10.106. Epub 2019 Oct 25.

PMID:
31669537
8.

High Serum Caspase-Cleaved Cytokeratin-18 Levels and Mortality of Traumatic Brain Injury Patients.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Argueso M, Ramos L, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Brain Sci. 2019 Oct 10;9(10). pii: E269. doi: 10.3390/brainsci9100269.

9.

Non-survivor patients with malignant middle cerebral artery infarction showed persistently high serum malondialdehyde levels.

Lorente L, Martín MM, Abreu-González P, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

BMC Neurol. 2019 Oct 17;19(1):238. doi: 10.1186/s12883-019-1479-z.

10.

High Serum DNA and RNA Oxidative Damage in Non-surviving Patients with Spontaneous Intracerebral Hemorrhage.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Abreu-González P, Sabatel R, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, García-Marín V.

Neurocrit Care. 2019 Oct 9. doi: 10.1007/s12028-019-00864-8. [Epub ahead of print]

PMID:
31598840
11.

The Serum Melatonin Levels and Mortality of Patients with Spontaneous Intracerebral Hemorrhage.

Lorente L, Martín MM, Abreu-González P, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Brain Sci. 2019 Oct 1;9(10). pii: E263. doi: 10.3390/brainsci9100263.

12.

High Serum sCD40L Levels During the First Week of Malignant Middle Cerebral Artery Infarction and Mortality.

Lorente L, Martín MM, González-Rivero AF, Sabatel R, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Alvarez-Castillo A, Jiménez A, Borreguero-León JM, García-Marín V.

World Neurosurg. 2019 Dec;132:e630-e636. doi: 10.1016/j.wneu.2019.08.060. Epub 2019 Aug 21.

PMID:
31442656
13.

Persistently High Serum Substance P Levels and Early Mortality in Patients with Severe Traumatic Brain Injury.

Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Argueso M, Ramos L, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

World Neurosurg. 2019 Dec;132:e613-e617. doi: 10.1016/j.wneu.2019.08.064. Epub 2019 Aug 20.

PMID:
31442647
14.

Association between DNA and RNA oxidative damage and mortality in septic patients.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Abreu-González P, Ortiz-López R, Ferreres J, Solé-Violán J, Labarta L, Díaz C, Palmero S, Jiménez A.

J Crit Care. 2019 Dec;54:94-98. doi: 10.1016/j.jcrc.2019.08.008. Epub 2019 Aug 5.

PMID:
31401543
15.

Association Between DNA and RNA Oxidative Damage and Mortality of Patients with Traumatic Brain Injury.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Abreu-González P, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Alvarez-Castillo A, Jiménez A, García-Marín V.

Neurocrit Care. 2019 Aug 5. doi: 10.1007/s12028-019-00800-w. [Epub ahead of print]

PMID:
31385181
16.

High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients.

Lorente L, Martín MM, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, Borreguero-León JM, González-Rivero AF, Orbe J, Rodríguez JA, Páramo JA.

BMC Neurol. 2019 Jul 18;19(1):167. doi: 10.1186/s12883-019-1401-8.

17.

Serum Caspase-3 Levels and Early Mortality of Patients with Malignant Middle Cerebral Artery Infarction.

Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Neurocrit Care. 2019 Dec;31(3):486-493. doi: 10.1007/s12028-019-00739-y.

PMID:
31115825
18.

High serum caspase-3 levels in hepatocellular carcinoma prior to liver transplantation and high mortality risk during the first year after liver transplantation.

Lorente L, Rodriguez ST, Sanz P, González-Rivero AF, Pérez-Cejas A, Padilla J, Díaz D, González A, Martín MM, Jiménez A, Cerro P, Portero J, Barrera MA.

Expert Rev Mol Diagn. 2019 Jul;19(7):635-640. doi: 10.1080/14737159.2019.1619549. Epub 2019 May 20.

PMID:
31084510
19.

Low Serum Melatonin Levels Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma are Associated with Lower Survival after Liver Transplantation.

Lorente L, Rodriguez ST, Sanz P, Abreu-González P, González-Rivero AF, Pérez-Cejas A, Padilla J, Díaz D, González A, Martín MM, Jiménez A, Cerro P, Portero J, Barrera MA.

Int J Mol Sci. 2019 Apr 5;20(7). pii: E1696. doi: 10.3390/ijms20071696.

20.

Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained High Serum sCD40L Levels.

Lorente L, Martín MM, González-Rivero AF, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, Borreguero-León JM, García-Marín V.

World Neurosurg. 2019 Jun;126:e1537-e1541. doi: 10.1016/j.wneu.2019.03.179. Epub 2019 Mar 27.

PMID:
30926559

Supplemental Content

Loading ...
Support Center